KLF17P1

Across TCGA pan-cancer cohorts, KLF17P1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of KLF17P1’s most consistent transcriptional readouts.

The strongest signal is observed in rectum adenocarcinoma (READ), where KLF17P1 RNA is repressed in tumor relative to normal tissue. In most cancer types KLF17P1 is over-expressed in tumor, although a few such as READ show the opposite, repressed pattern.

READ, KIRC, and THCA are the cancer types where KLF17P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KLF17P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
READ	All	III,IV	−0.075	.037	2	view →
KIRC	Male	II,III,IV	+0.035	.027	2	view →
THCA	Male	IV	+0.090	.012	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

KLF17P1–READ

Open the READ breakdown →